Huamao Lin, based in Arlington, MA, US, is currently a Head of Global Evidence and Outcome Research, Solid Tumor at Takeda Oncology, bringing experience from previous roles at Takeda Oncology, Resolvyx, Sino American Pharmaceutical Association (SAPA) and Altana Pharma (Nycomed, Later acquired by Takeda Pharma). Huamao Lin holds a 1992 - 1998 Ph.D in Division of Medical Science @ Harvard University. With a robust skill set that includes Biotechnology, Drug Discovery, Lifesciences, Pharmaceutical Industry, Oncology and more, Huamao Lin contributes valuable insights to the industry. Huamao Lin has 2 emails on RocketReach.